🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 135 of 151

  1. VYN201 Gel

    VYNE Therapeutics

    Non-segmental Vitiligo

    phase 2 small molecule terminated

    1 trial

  2. Vaborem 1 g/1 g powder for concentrate for solution for infusion

    A.Menarini Australia Pty Limited

    Suspected or confirmed Gram negative infections

    phase 2 small molecule active

    1 trial

  3. Vaccine

    Atrium Therapeutics

    Pediatric Cancer

    phase 2 mab active

    1 trial

  4. Vaccine PvCS N+C+R

    BRIGHT MINDS BIOSCIENCES INC.

    Malaria

    phase 2 mab completed

    1 trial

  5. Vaccine PvCS N+C+R 150 mcg

    BRIGHT MINDS BIOSCIENCES INC.

    Malaria, Vivax

    phase 2 mab active

    1 trial

  6. Vacuna Dermatophagoides mezcla Placebo, Vacuna Dermatophagoides mezcla 3000 TBU/ml, Test de provocación nasal, Vacuna Dermatophagoides mezcla 6000 TBU/ml, Vacuna Dermatophagoides mezcla 1000 TBU/ml

    Advanced Accelerator Applications

    Allergic rhinitis/rhinoconjunctivitis caused by dust mite allergy

    phase 2 small molecule active

    1 trial

  7. Vadadustat

    Akebia Europe Limited

    Chronic Kidney Disease

    phase 2 small molecule completed

    1 trial

  8. Valaciclovir/Aciclovir

    United Therapeutics Europe Ltd

    Critical Illness

    phase 2 small molecule completed

    1 trial

  9. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Tourette Syndrome

    phase 2 small molecule completed

    4 trials

  10. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Obsessive-Compulsive Disorder

    phase 2 small molecule active

    1 trial

  11. Valbenazine Oral Capsule

    NEUROCRINE BIOSCIENCES INC

    Trichotillomania (Hair-Pulling Disorder)

    phase 2 small molecule active

    1 trial

  12. Valemetostat Tosylate, Golcadomide, RITUXIMAB, Valemetostat Tosylate, Golcadomide, RITUXIMAB, Golcadomide

    Celgene Europe Limited

    Follicular B-cell non-Hodgkin's lymphoma, Primary central nervous system lymphoma, Marginal zone lymphoma, Diffuse large B-cell lymphoma, Mantle cell lymphoma

    phase 2 small molecule active

    1 trial

  13. Valemetostat Tosylate, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Valemetostat Tosylate

    Daiichi Sankyo

    Advanced or Metastatic Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  14. Valemetostat Tosylate, Valemetostat Tosylate

    The George Institute

    Adult patients with histologically/cytologically confirmed progressive metastatic or recurrent solid tumor, who have selected chromatin remodeling deficiency in at least one of the following genes: SMARCB1, SMARCA4, SMARCA2, SMARCC1, SMARCC2, ARID1A, ARID1B, PBRM1, BAP1and other SWI/SNF sub-units; or molecularly (Wildtype) and phenotypically-selected Clear cell endometrial or ovarian carcinoma cancers.

    phase 2 small molecule active

    1 trial

  15. Valemetostat Tosylate, Valemetostat Tosylate

    Daiichi Sankyo

    Relapsed/Refractory Peripheral T-Cell Lymphoma

    phase 2 small molecule active

    1 trial

  16. Valoctocogene roxaparvovec

    BioMarin Pharmaceutical Australia Pty Ltd

    Hemophilia A With Inhibitor

    phase 2 mab active

    1 trial

  17. Valproate

    BRIGHT MINDS BIOSCIENCES INC.

    Bipolar Disorder

    phase 2 small molecule completed

    1 trial

  18. Valproic Acid

    United Therapeutics Europe Ltd

    Retinitis Pigmentosa

    phase 2 small molecule completed

    1 trial

  19. Valproic Acid

    United Therapeutics Europe Ltd

    Pain, Phantom

    phase 2 small molecule completed

    1 trial

  20. Valproic Acid Solution

    United Therapeutics Europe Ltd

    Acute Kidney Injury

    phase 2 small molecule terminated

    1 trial

  21. Vancomycin

    Cardiff Oncology

    Late Onset Neonatal Sepsis

    phase 2 small molecule terminated

    1 trial

  22. Vancomycin Pre-Treatment

    Seres Therapeutics

    Ulcerative Colitis

    phase 2 small molecule terminated

    1 trial

  23. Vancomycin and bowel lavage

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Slow Transit Constipation

    phase 2 small molecule active

    1 trial

  24. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Dependence

    phase 2 small molecule completed

    1 trial

  25. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use

    phase 2 small molecule active

    1 trial

  26. Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule terminated

    2 trials

  27. Varenicline Adaptive Protocol

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial

  28. Varnimcabtagene autoleucel, BENDAMUSTINE, FLUDARABINE, DEXCHLORPHENIRAMINE, CYCLOPHOSPHAMIDE, PARACETAMOL, TOCILIZUMAB, ALLOPURINOL

    The George Institute

    Acute lymphoid leukemia

    phase 2 small molecule active

    1 trial

  29. Vasopressin

    United Therapeutics Europe Ltd

    Traumatic Shock

    phase 2 small molecule completed

    1 trial

  30. Vebreltinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Potentially Resectable MET-altered Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  31. Vectibix 20 mg/ml concentrate for solution for infusion, VALPROIC ACID, VALPROIC ACID, Irinotecan Accord 20 mg/ml concentrato per soluzione perinfusione

    Fondazione Telethon ETS

    RAS/BRAF wild-type metastatic colorectal cancer

    phase 2 small molecule active

    1 trial

  32. Vedolizumab

    Takeda

    Celiac Disease

    phase 2 small molecule terminated

    1 trial

  33. Vedolizumab

    Takeda

    Collagenous Gastritis

    phase 2 mab active

    1 trial

  34. Vedolizumab

    Takeda

    Allogeneic Hematopoietic Stem Cell Transplantation

    phase 2 small molecule completed

    2 trials

  35. Vedolizumab 300 MG Injection [Entyvio]

    Takeda

    Immune Checkpoint Inhibitor-Related Colitis

    phase 2 small molecule active

    1 trial

  36. Vedolizumab intravenous injection

    Takeda

    Ulcerative Colitis

    phase 2 small molecule terminated

    1 trial

  37. Vehicle

    Aclaris Therapeutics

    Alopecia Universalis (AU)

    phase 2 small molecule completed

    1 trial

  38. Vehicle (Isocyclosporin A 0 mg/mL, 0%), Isocyclosporin A, TROPICAMIDE , SODIUM CHLORIDE , OXYBUPROCAINE

    Dompe' Farmaceutici S.p.A.

    Atopic keratoconjunctivitis (AKC)

    phase 2 small molecule active

    1 trial

  39. Vehicle of TP-03

    Tarsus Pharmaceuticals

    Meibomian Gland Dysfunction

    phase 2 small molecule active

    1 trial

  40. Vehicle to TOP-N53, TOP-N53, Sildenafil Teva 20 mg filmomhulde tabletten

    Lacuna Pharma Pty Ltd

    Digital ulcers in systemic sclerosis

    phase 2 small molecule active

    1 trial

  41. Vehicle, Cenegermin

    Dompe' Farmaceutici S.p.A.

    Subacute Moderate to Severe Traumatic Brain Injury (TBI)

    phase 2 small molecule active

    1 trial

  42. Veklury 100 mg powder for concentrate for solution for infusion

    MEDA Pharma GmbH & Co. KG

    COVID-10 infection

    phase 2 small molecule active

    1 trial

  43. Veltuzumab

    Takeda

    Rheumatoid Arthritis

    phase 2 small molecule terminated

    1 trial

  44. Velusetrag

    Theravance Biopharma Ireland Umited

    Gastroparesis

    phase 2 small molecule completed

    1 trial

  45. Venclyxto 100 mg film-coated tablets, Azacitidine Kabi 25 mg/mL powder for suspension for injection

    The George Institute

    acute myeloid leukemia

    phase 2 small molecule active

    1 trial

  46. Venclyxto 100 mg film-coated tablets, RITUXIMAB, Calquence 100 mg film-coated tablets, Venclyxto 50 mg film-coated tablets, RITUXIMAB, Venclyxto 10 mg film-coated tablets

    AstraZeneca AB

    Treatment Naïve Mantle Cell Lymphoma

    phase 2 small molecule active

    1 trial

  47. Venclyxto 100 mg film-coated tablets, Venclyxto 100 mg film-coated tablets, Calquence 100 mg film-coated tablets, Venclyxto 50 mg film-coated tablets, Venclyxto 100 mg film-coated tablets, Venclyxto 10 mg film-coated tablets

    AstraZeneca AB

    Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

    phase 2 small molecule active

    1 trial

  48. Venclyxto 50 mg film-coated tablets, JNJ-54179060, Venclyxto 100 mg film-coated tablets, Venclyxto 10 mg film-coated tablets, Venclyxto 100 mg film-coated tablets, IMBRUVICA 140 mg hard capsules

    Janssen-Cilag International N.V.

    Untreated Chronic Lymphocytic Leukemia

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.